Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: HELIX OPCO LLC
Awarding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Funding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Period of performance: 2022-09-30 to 2023-09-29
Current total value of award: $2190000
Description: FY22 BAA - TOPIC 7 - IDENTIFYING VIRAL AND HOST  GENETIC DETERMINANTS OF VACCINE EFFICACY